Top Markets
Coin of the day
OncoVista Innovative Therapies, Inc. OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc.

OVIT
Rank in Stocks #42300
OncoVista Innovative Therapies, Inc. does not have significant business.... OncoVista Innovative Therapies, Inc. does not have significant business. Previously, it engaged in development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$2.36K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade OncoVista Innovative Therapies, Inc. (OVIT)

Category

Operating Margin for OncoVista Innovative Therapies, Inc. (OVIT)
Operating Margin as of 2026 TTM: 0.00%
According to OncoVista Innovative Therapies, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for OncoVista Innovative Therapies, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
31.23% -
BE
0.00% -
KR
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.